Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Lanying Du and Naru Zhang.
Lanying Du
Connection Strength
3.320
Naru Zhang
  1. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies. Expert Rev Vaccines. 2020 09; 19(9):817-829.
    View in: PubMed
    Score: 0.902
  2. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell Mol Immunol. 2016 Mar; 13(2):180-90.
    View in: PubMed
    Score: 0.612
  3. Receptor-binding domain-based subunit vaccines against MERS-CoV. Virus Res. 2015 Apr 16; 202:151-9.
    View in: PubMed
    Score: 0.603
  4. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines. 2014 Jun; 13(6):761-74.
    View in: PubMed
    Score: 0.580
  5. Current development of COVID-19 diagnostics, vaccines and therapeutics. Microbes Infect. 2020 Jul - Aug; 22(6-7):231-235.
    View in: PubMed
    Score: 0.220
  6. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020 04; 92(4):408-417.
    View in: PubMed
    Score: 0.216
  7. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design. Vaccine. 2014 Oct 21; 32(46):6170-6176.
    View in: PubMed
    Score: 0.149
  8. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus. Hum Vaccin Immunother. 2015; 11(5):1244-50.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.